Skip to Main Content

pain

Here’s the latest research and news on pain, a complex and multifaceted experience that can have a profound impact on people’s lives. Topics include the causes of pain, the latest treatments, and the challenges of living with chronic pain.

Latest

Biotech Allison DeAngelis

STAT Plus: Biotech launches with $135 million for Vertex-competing pain medicine

The Readout LOUD Damian Garde, Allison DeAngelis, and Adam Feuerstein

Listen: Vertex’s polarizing data, Aduhelm’s adieu, & an FDA icon

Adam's Take Adam Feuerstein

STAT Plus: Can gene therapies make for a profitable business? Keep your eye on Bluebird Bio

Biotech Jonathan Wosen

STAT Plus: Vertex pain drug results met with measured optimism — and questions — by observers and experts

Biotech Jonathan Wosen

STAT Plus: Vertex’s closely watched pain relief drug succeeds in late-stage trials — with a catch

Health tech Mario Aguilar

STAT Plus: How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed

The Readout Damian Garde

STAT Plus: No pain data yet from Vertex, and sky high deal expectations at JPM 2024

Health tech Lizzy Lawrence

STAT Plus: SEC charges former CEO of pain relief device company with $41 million fraud

All Coverage

Health Associated Press

Mind-altering ketamine becomes latest pain treatment, despite little research or regulation

Exclusive Lev Facher

Markey and Manchin urge FDA to stop its study of opioids for chronic pain

advertisement

Health Jonathan Wosen

STAT Plus: Vertex non-opioid therapy reduced pain in mid-stage trials, study shows

Living With Isabella Cueto

A rare disease has run through five generations of his family, so he’s built community for others

Health Isabella Cueto

Black former NFL players more burdened by chronic pain than white counterparts, study finds

Health Isabella Cueto

Bacterial infection may be ‘key event’ in common but mysterious endometriosis, study says

Special Report Lizzy Lawrence

STAT Plus: Lured by a bigger payday, a medical device maker sold fake plastic parts. Many were implanted in chronic pain patients

Health Isabella Cueto

‘I’m terrified’: Patients scramble for treatment after 13 ketamine clinics shut down

Pharmalot Ed Silverman

STAT Plus: Medicare Part D plans authorized opioid prescriptions for cancer pain — to people without cancer

Biotech Jonathan Wosen

STAT Plus: Biosplice, once the most valuable biotech startup, sees a pair of osteoarthritis trials fail

Health Isabella Cueto

Common injections don’t help knee osteoarthritis more than placebo, large data review finds

Health Elissa Welle

Enrollment in medical cannabis programs saw four-fold increase, study finds

In the Lab Jason Mast

In radical claim, study suggests inflammation wards off chronic pain instead of causing it

First Opinion Podcast Patrick Skerrett

Listen: How should doctors treat chronic pain in the wake of the opioid crisis?

First Opinion Shravani Durbhakula and Joshua M. Sharfstein

HHS needs to step up so CDC’s new guidelines won’t be ‘a bridge to nowhere’ for most Americans living with chronic pain

First Opinion Antje M. Barreveld

As a pain specialist, I may have caused more harm by underprescribing opioids

The Readout LOUD Adam Feuerstein and Meg Tirrell

Listen: What’s next for Roche, a debate over second boosters, & Vertex’s recent success

Biotech Damian Garde

STAT Plus: Vertex’s non-opioid painkiller meets goals in mid-stage studies

First Opinion Kate M. Nicholson

Another fight for Covid long-haulers: having their pain acknowledged

Health Nicholas StFleur and Eric Boodman

STAT Plus: STAT+ Conversation: Pain and Promise: Examining a fibromyalgia blood test

A STAT Investigation Eric Boodman

Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?